# Endometrial and Ovarian Tumours for NEET PG OBG: Postmenopausal Bleeding, Endometrial Cancer Risks, Ovarian Cancer Markers, Benign Masses and Torsion

Source: https://tracknation.in/story/endometrial-and-ovarian-tumours-for-neet-pg-obg-postmenopausal-bleeding-endometrial-cancer-risks-ovarian-cancer-markers-benign-masses-and-torsion (TrackNation — free UPSC notes with PYQs)

> NEET PG Gynaecology: endometrial cancer (presentation, risk factors, TVS and biopsy, surgical staging and treatment), ovarian cancer (high-grade serous, BRCA, protective factors, CA 125 and germ-cell markers, ultrasound red flags, cytoreduction and chemotherapy), benign adnexal masses, Meigs syndrome and adnexal torsion, with a diagram, hooks, vignette MCQs and cards.

## Start Here

🎯 **Exam priority: High.** *Expect: postmenopausal bleeding work-up, endometrial cancer risk factors (unopposed oestrogen,
tamoxifen, Lynch), surgical staging, ovarian cancer histology and BRCA, marker by age (CA 125 vs AFP/hCG/LDH/inhibin), ultrasound red flags,
Meigs syndrome, and recognising torsion.*

CBME mapping: **OG34**. Cervical cancer is in OBG 24.

*Endometrial and ovarian tumours, benign masses and torsion. Drawn by TrackNation.*

## Endometrial Cancer (MSD, ICMR)

- Usually **endometrioid adenocarcinoma**; **>90%** present with abnormal bleeding — classically
**postmenopausal bleeding (PMB)**. **6–19%** of women with PMB have endometrial cancer. About 80% are found early (good prognosis).

- Risks: **unopposed oestrogen** (anovulation/PMOS, oestrogen without progestogen, oestrogen-secreting tumours), **obesity**,
**age >45**, **tamoxifen >2 years**, **Lynch syndrome**, pelvic radiation, nulliparity, early menarche, late menopause.

- Diagnosis: **endometrial biopsy** (sensitivity >90%); TVS is an alternative in average-risk postmenopausal women — **biopsy if the
endometrium is >4 mm**; D&C ± hysteroscopy if inconclusive. ICMR: recurrent PMB is an indication for hysterectomy even without cancer.

- **Staging is surgical**: **total hysterectomy + bilateral salpingo-oophorectomy**; pelvic/para-aortic nodes for deep (>50%)
invasion, grade 3 or high-risk histology; radiation ± chemotherapy for stage II–III.

## Ovarian Cancer (MSD)

- Second commonest gynaecological cancer in the US; often fatal because it is **diagnosed late** (symptoms vague). Commonest type:
**high-grade serous epithelial** cancer, grouped with fallopian-tube and peritoneal cancers. Spread: direct, **peritoneal seeding**,
lymphatics.

- Risk: nulliparity, early menarche, late menopause, family/personal history of breast, endometrial or colon cancer; **BRCA1/2 germline in
14–18%** of high-grade serous cancers. **Oral contraceptives lower risk**.

- Other types: **germ cell** (dysgerminoma, endodermal sinus, immature teratoma, choriocarcinoma) — usually **under 30**, and XY gonadal
dysgenesis predisposes; **sex cord–stromal** (granulosa-theca, Sertoli–Leydig); metastases (breast, GI).

- Markers: **young women — β-hCG, LDH, AFP, inhibin** (plus CA 125); **peri/postmenopausal — CA 125** (raised in 80% of advanced
epithelial cancers; can be normal early; also raised in endometriosis, PID, pregnancy).

- Ultrasound red flags: **solid component, surface excrescences, >6 cm, irregular, low-resistance flow**. Mass + ascites usually means
cancer — unless **Meigs syndrome** (benign fibroma + ascites + right hydrothorax).

- Treatment: **hysterectomy, BSO and maximal cytoreduction**, then **carboplatin + paclitaxel**; neoadjuvant chemotherapy if not
operable first; fertility-sparing surgery possible for stage I non-epithelial tumours.

## Benign Adnexal Masses and Torsion (MSD, ICMR)

- Benign masses: **functional cysts** (follicular, corpus luteum), endometriomas, **theca lutein cysts** (ovulation induction),
**fibromas, cystadenomas, benign cystic teratomas (dermoids)**, paraovarian cysts. Surgery (cystectomy/oophorectomy) if symptomatic or cancer
is suspected.

- ICMR: a **simple ovarian cyst <5 cm** without suspicious features is **observed and reviewed at 6 months** — no hysterectomy.

- **Adnexal torsion** — a common gynaecological emergency: twisting cuts the arterial supply; usually an **enlarged ovary or mass**;
**sudden severe pain with nausea and vomiting**. TVS shows an enlarged ovary/mass; **Doppler: reduced or absent flow**. Suspicion alone →
**immediate laparoscopy** to save the ovary.

## Traps the Examiner Sets

- Postmenopausal bleeding = endometrial cancer until proved otherwise.

- Tamoxifen protects the breast but raises endometrial cancer risk.

- CA 125 can be normal in early ovarian cancer and raised in benign conditions.

- Pelvic mass + ascites + right pleural effusion with a benign fibroma = Meigs syndrome.

## Memory Hooks & Shortcuts

*Shortcuts to lock in this article's numbers and lists. Each one only re-packages facts proven above.*

- 🧠 **'Bleeding after the menopause = biopsy' (TVS over 4 mm)** — PMB

- 🧠 **Endometrial risks 'Fat, Unopposed, Tamoxifen, Lynch'** — risks

- 🧠 **Markers by age: 'Young = AFP, hCG, LDH, inhibin; Old = CA 125'** — markers

- 🧠 **Meigs 'Fibroma, Fluid (ascites), right Flank (hydrothorax)'** — Meigs

- 🧠 **Torsion 'Twist, Vomit, No flow, Operate now'** — torsion

## Rapid-Revision Cards

- Endometrioid adenocarcinoma.

- >90% abnormal bleeding (PMB).

- 6–19%.

- Unopposed oestrogen, obesity, tamoxifen, Lynch.

- Biopsy if ET >4 mm.

- >90%.

- Surgical: TH + BSO.

- Grade 3 or >50% invasion.

- Hysterectomy (ICMR).

- High-grade serous.

- Late diagnosis.

- 14–18% of HGSOC.

- Oral contraceptives.

- <30.

- hCG, LDH, AFP, inhibin.

- CA 125.

- Solid, >6 cm, excrescences.

- Fibroma + ascites + right effusion.

- Cytoreduction + carbo/paclitaxel.

- Observe 6 months.

- Pain + vomiting; absent flow; laparoscopy.

## Sources

*Facts in this article were checked against these documents.*

- MSD Manual Professional: Endometrial Cancer; Ovarian, Fallopian Tube, and Peritoneal Cancer; Benign Adnexal Masses; Adnexal Torsion — Merck & Co. (MSD Manuals), 2023–26 (link)

- Standard Treatment Workflow: Hysterectomy for Benign Gynaecological Conditions — Indian Council of Medical Research / DHR, 2025

- Competency Based Undergraduate Curriculum, Vol III: Obstetrics & Gynaecology (OG34) — National Medical Commission, 2024

## Test Yourself: Practice Questions

Thirty questions in NEET PG style, most of them clinical vignettes.

## Practice Questions (NEET PG pattern)

*Original questions written in the style of the exam: +4 for a correct answer, −1 for a wrong one. Every answer
was checked against the sources listed above. NEET PG papers are not published by NBEMS, so these are not past-paper questions.*

**Q1.** The commonest histology of endometrial cancer is

- (a) leiomyosarcoma

- (b) squamous carcinoma

- (c) clear cell carcinoma

- (d) endometrioid adenocarcinoma

**Answer: (d)** — MSD.

**Q2.** A 60-year-old has postmenopausal bleeding. The proportion of such women with endometrial cancer is about

- (a) 60–80%

- (b) 6–19%

- (c) <1%

- (d) 50%

**Answer: (b)** — Investigate every PMB.

**Q3.** More than 90% of women with endometrial cancer present with

- (a) pelvic mass

- (b) abnormal uterine bleeding

- (c) ascites

- (d) bone pain

**Answer: (b)** — PMB classic.

**Q4.** Which is a risk factor for endometrial cancer?

- (a) combined oral contraceptive use

- (b) multiparity

- (c) smoking

- (d) tamoxifen use for more than 2 years

**Answer: (d)** — Also Lynch, obesity.

**Q5.** An obese 55-year-old nullipara with PMOS (PCOS) history has PMB. Her key risk mechanism is

- (a) HPV infection

- (b) high progesterone

- (c) unopposed oestrogen

- (d) BRCA mutation

**Answer: (c)** — MSD.

**Q6.** An inherited syndrome raising endometrial cancer risk is

- (a) Marfan syndrome

- (b) Turner syndrome

- (c) Down syndrome

- (d) Lynch syndrome

**Answer: (d)** — Also colon cancer.

**Q7.** In an average-risk woman with PMB, TVS shows endometrium of 7 mm. Next:

- (a) repeat scan in 5 years

- (b) HRT

- (c) reassure

- (d) endometrial biopsy

**Answer: (d)** — >4 mm.

**Q8.** Office endometrial biopsy for endometrial cancer has a sensitivity of

- (a) about 50%

- (b) >90%

- (c) 100% always

- (d) about 20%

**Answer: (b)** — D&C if inconclusive.

**Q9.** Endometrial cancer is staged

- (a) by Pap smear

- (b) surgically

- (c) clinically only

- (d) by CA 125

**Answer: (b)** — FIGO.

**Q10.** Standard surgery for early endometrial cancer is

- (a) cone biopsy

- (b) endometrial ablation

- (c) total hysterectomy with bilateral salpingo-oophorectomy

- (d) myomectomy

**Answer: (c)** — ± nodes.

**Q11.** Lymphadenectomy in endometrial cancer is indicated for

- (a) only if CA 125 is high

- (b) all grade 1 superficial tumours

- (c) grade 3 tumours or deep (>50%) myometrial invasion

- (d) never

**Answer: (c)** — And high-risk histology.

**Q12.** Per ICMR, recurrent postmenopausal bleeding even without cancer may justify

- (a) observation forever

- (b) oestrogen therapy

- (c) tamoxifen

- (d) hysterectomy

**Answer: (d)** — 2025 STW.

**Q13.** The commonest histological type of ovarian cancer is

- (a) granulosa cell tumour

- (b) Krukenberg tumour

- (c) dysgerminoma

- (d) high-grade serous epithelial

**Answer: (d)** — MSD.

**Q14.** Ovarian cancer is often fatal mainly because

- (a) it metastasises to brain first

- (b) it occurs in children

- (c) it is resistant to all treatment

- (d) it is usually advanced when diagnosed

**Answer: (d)** — Vague symptoms.

**Q15.** Germline BRCA1/2 mutations are found in what share of high-grade serous ovarian cancers?

- (a) 90%

- (b) 50%

- (c) 1%

- (d) 14–18%

**Answer: (d)** — MSD.

**Q16.** A factor that lowers ovarian cancer risk is

- (a) early menarche

- (b) oral contraceptive use

- (c) nulliparity

- (d) late menopause

**Answer: (b)** — MSD.

**Q17.** Ovarian germ cell cancers usually occur in women aged

- (a) any age equally

- (b) 40–50

- (c) under 30

- (d) over 60

**Answer: (c)** — Check AFP, hCG, LDH.

**Q18.** A 19-year-old has a solid ovarian mass. Markers to order include

- (a) β-hCG, LDH, AFP and inhibin (plus CA 125)

- (b) PSA

- (c) CA 125 only

- (d) CEA only

**Answer: (a)** — Non-epithelial.

**Q19.** In a postmenopausal woman with an ovarian mass, the marker measured is

- (a) CA 125

- (b) AFP

- (c) β-hCG

- (d) inhibin

**Answer: (a)** — Mostly epithelial.

**Q20.** CA 125 in ovarian cancer

- (a) is a germ-cell marker

- (b) is raised in 80% of advanced epithelial cancers but may be normal early

- (c) is specific for cancer

- (d) is always raised in stage I

**Answer: (b)** — Also raised in endometriosis, PID.

**Q21.** A woman with endometriosis has a mildly raised CA 125. This

- (a) proves ovarian cancer

- (b) can occur in benign conditions

- (c) proves pregnancy

- (d) is impossible

**Answer: (b)** — Low specificity.

**Q22.** Which ultrasound feature suggests ovarian malignancy?

- (a) follicle of 2 cm

- (b) corpus luteum

- (c) simple thin-walled 3 cm cyst

- (d) solid component with surface excrescences, >6 cm

**Answer: (d)** — Also irregular, low resistance.

**Q23.** A woman has a benign ovarian fibroma with ascites and a right pleural effusion. Diagnosis:

- (a) Krukenberg tumour

- (b) Fitz-Hugh–Curtis syndrome

- (c) Meigs syndrome

- (d) ovarian cancer stage IV

**Answer: (c)** — Benign.

**Q24.** Standard treatment of advanced epithelial ovarian cancer is

- (a) observation

- (b) hysterectomy, BSO and maximal cytoreduction then chemotherapy

- (c) radiotherapy alone

- (d) hormone therapy alone

**Answer: (b)** — Carboplatin + paclitaxel.

**Q25.** The standard chemotherapy pair for epithelial ovarian cancer is

- (a) cisplatin and 5-FU only

- (b) tamoxifen and letrozole

- (c) methotrexate and folinic acid

- (d) carboplatin and paclitaxel

**Answer: (d)** — MSD.

**Q26.** A 22-year-old with stage I dysgerminoma wants children. MSD allows

- (a) fertility-sparing surgery conserving the other ovary and uterus

- (b) mandatory hysterectomy

- (c) no surgery

- (d) radiotherapy only

**Answer: (a)** — Stage I non-epithelial.

**Q27.** A woman on ovulation induction develops bilateral large ovarian cysts. These are likely

- (a) malignant

- (b) dermoid cysts

- (c) theca lutein cysts

- (d) endometriomas

**Answer: (c)** — MSD.

**Q28.** A 32-year-old has an incidental simple 4 cm ovarian cyst. ICMR advises

- (a) CA 125 monthly

- (b) oophorectomy

- (c) hysterectomy

- (d) observation and review after 6 months

**Answer: (d)** — No suspicious features.

**Q29.** A 24-year-old with a known 7 cm dermoid has sudden severe pelvic pain and vomiting; Doppler shows absent ovarian flow. Diagnosis:

- (a) ruptured ectopic

- (b) adnexal torsion

- (c) PID

- (d) appendicitis

**Answer: (b)** — Emergency.

**Q30.** When adnexal torsion is suspected, management is

- (a) immediate laparoscopy to save the ovary

- (b) repeat scan next week

- (c) antibiotics

- (d) wait for 48 hours

**Answer: (a)** — Don't delay.

### Active Recall

From memory: describe endometrial cancer presentation, risk factors, diagnosis and staging; ovarian cancer types, risk modifiers, markers by age, ultrasound red flags and treatment; and the management of benign adnexal masses and torsion.
